Adivaraha Jayasankar is a notable inventor based in Naperville, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid pharmaceutical compositions.

Latest Patents

Jayasankar holds two patents, with his latest inventions focusing on innovative pharmaceutical formulations. One of his patents is for solid pharmaceutical compositions for treating HCV. This invention features a composition that includes a first layer comprising 100 mg of Compound 1, along with a pharmaceutically acceptable hydrophilic polymer and a surfactant, all formulated in amorphous solid dispersion. The second layer consists of 40 mg of Compound 2, also combined with a hydrophilic polymer and surfactant in a similar formulation. His other patent involves formulations of phenyl uracil compounds, which include at least one phenyl uracil-based pharmaceutically active agent and processes for obtaining such products.

Career Highlights

Adivaraha Jayasankar is currently associated with AbbVie Inc., where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug formulations that aim to improve patient outcomes.

Collaborations

Some of his notable coworkers include Nancy E Sever and Ulrich Westedt, who collaborate with him on various projects within the company.

Conclusion

Adivaraha Jayasankar's contributions to pharmaceutical innovations highlight his expertise and commitment to improving healthcare solutions. His patents reflect a dedication to advancing treatment options for diseases such as HCV.

This text is generated by artificial intelligence and may not be accurate.